Mosapramine
Top View
- Drug/Substance Trade Name(S)
- (2006.01) A61P 25/36 (2006.01) A61K 9/00 (2006.01) (21) International Application Number: PCT/US20 19/059852 (22) International Filing Date: 05 November 2019 (05
- (12) United States Patent (10) Patent No.: US 7,199,151 B2 Shashoua Et Al
- (12) United States Patent (10) Patent No.: US 8,314,077 B2 Webb Et Al
- Poison Or Antibiotic? a Guide to "Class" Entries
- 2020 Equine Prohibited Substances List
- 1 Proposal for Drug Coding of “List of Drugs to Be Prescribed with Special
- Generation Antipsychotics for Children and Young Adults Comparative Effectiveness Review Number 39
- NVA237 / Glycopyrronium Bromide Multinational, Multi-Database Cohort
- Iminodibenzyl Class Antipsychotics for Schizophrenia: a Systematic Review and Meta-Analysis of Carpipramine, Clocapramine, and Mosapramine
- KENTUCKY HORSE RACING Chapter: \810\008.020REG
- Psychopharmaceuticals in Japan
- Pharmaceuticals and Medical Devices Safety Information No
- WO 2014/018563 A2 30 January 2014 (30.01.2014)
- New Drug Evaluation Monograph Template
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
- Encyclopedia of Schizophrenia Focus on Management Options W
- Summary of Investigation Results Antipsychotic Agents, Etc